Technical Analysis for RLMD - Relmada Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 33.98 -1.28% -0.44
RLMD closed down 1.28 percent on Tuesday, October 20, 2020, on 2.22 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical RLMD trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Volume Surge Other -1.28%
Lower Bollinger Band Walk Weakness -1.28%
Below Lower BB Weakness -1.28%
Older End-of-Day Gignals for RLMD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
Rose Above Previous Day's High about 16 hours ago
3x Volume Pace about 16 hours ago
2x Volume Pace about 16 hours ago
1.5x Volume Pace about 16 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Relmada Therapeutics is a clinical-stage, publicly traded biotechnology company developing novel medicines that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases. Relmada's lead program, dextromethadone (REL-1017), is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with a variety of cognitive, neurological and behavioral symptoms.
Biotechnology Diseases Neuroscience Neurochemistry Drug Rehabilitation Nmda Receptor Antagonists

Is RLMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 54.0
52 Week Low 21.85
Average Volume 78,403
200-Day Moving Average 40.23
50-Day Moving Average 37.36
20-Day Moving Average 37.33
10-Day Moving Average 36.72
Average True Range 2.02
ADX 18.06
+DI 9.99
-DI 18.31
Chandelier Exit (Long, 3 ATRs ) 34.41
Chandelier Exit (Short, 3 ATRs ) 39.93
Upper Bollinger Band 40.76
Lower Bollinger Band 33.89
Percent B (%b) 0.01
BandWidth 18.40
MACD Line -0.78
MACD Signal Line -0.25
MACD Histogram -0.5256
Fundamentals Value
Market Cap 544.49 Million
Num Shares 16 Million
EPS -1.68
Price-to-Earnings (P/E) Ratio -20.24
Price-to-Sales 0.00
Price-to-Book 4.73
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.46
Resistance 3 (R3) 37.81 37.00 36.88
Resistance 2 (R2) 37.00 36.11 36.83 36.69
Resistance 1 (R1) 35.49 35.57 35.09 35.14 36.49
Pivot Point 34.68 34.68 34.48 34.51 34.68
Support 1 (S1) 33.17 33.79 32.77 32.82 31.47
Support 2 (S2) 32.36 33.25 32.19 31.27
Support 3 (S3) 30.85 32.36 31.08
Support 4 (S4) 30.50